Prof. Dr. Raja Atreya

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

BrainInsights: a comprehensive framework for pre-processing, analysis, and interpretation of neuroimaging data using traditional statistics and machine learning (2026) Selvakumar M, Mendez Torrijos A, Konerth L, Horndasch S, Atreya R, Dörfler A, Schett G, et al. Journal article Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review (2026) Vieujean S, Atreya R, Buda A, Caradec J, Citi S, Danese S, Dewit O, et al. Journal article, Review article Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study (2026) Cohen NA, Bettenworth D, Sror N, Khedraki R, Yang Q, Abreu MT, Atreya R, et al. Journal article, Review article Long-Term Safety of Upadacitinib in Patients With Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies (2026) Panaccione R, Panés J, Peyrin-Biroulet L, Colombel JF, Lindsay JO, Baert F, Atreya R, et al. Journal article Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease (2026) Reinisch W, Atreya R, Rieder F, Jairath V, Rimola J, Peyrin-Biroulet L, Tozer P, et al. Journal article, Review article Successful treatment of severe retroauricular pyoderma gangrenosum with upadacitinib in a patient with Crohn’s disease and a history of cerebral venous sinus thrombosis (2026) Fousekis F, Ronicke M, Sollfrank L, Rech J, Berking C, Neurath MF, Sticherling M, Atreya R Journal article Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease (2026) Orlemann T, Zimmermann D, Hübner H, Atreya R, Bodenschatz J, Noviello D, Vitali F, et al. Journal article Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A (2026) Sergeev M, Meier M, Wohlleben P, Rupprecht L, Kupraszewicz-Hutzler M, Hilgers KF, Hartner A, et al. Journal article Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitis (2026) Atreya R, Neurath M Journal article Efficacy and health-related quality of life associated with second-line vedolizumab after first-line treatment with one anti-TNF in patients with ulcerative colitis: a meta-analysis of the GEMINI-1 and VISIBLE-1 trials (2026) Atreya R, Kirchgesner J, Cheah Z, Biedermann P, Bakker L, Meyer M, Raine T Journal article